Atturos CSO Stephen Pennington attended two conferences this month and spoke about the Atturos biomarker development pipeline and progress with the OCProDx test.
At the 2nd Personalised Medicine Conference in Cancun, Mexico Stephen was invited to deliver a presentation entitled; “Design, Development and Delivery of Multiplexed Protein Biomarker Tests to Support Clinical Decision Making”. Atturos Advisor Jennifer Van Eyk was also in attendance and delivered a talk of her own about high throughput microsampling and mass spectrometry.
For the second year in a row Stephen also attended the GTC Biomarker Summit in San Diego as an invited speaker. Here he spoke again of the development of the OCProDx test and also chaired and moderated a rountable about the pathologic potential of blood biomarkers.
Future featured speaking engagements include a HUPO Workshop on Precision Medicine in Germany (April 2nd), and the 3rd Annual John Fitzpatrick Irish Genito-Urinary Cancer Conference 2017 (April 6th-7th). Stephen will also be pitching as one of the Top 10 Finalists of the AIB Start up Academy Competition on the 20th of April.